ÂÜÀòÂÒÂ×

Irem brings over a decade of investing and operating experience across various stages of healthcare services and healthcare technology companies. At Norwest, she focuses on venture and growth equity opportunities across healthcare services, healthcare IT, pharma services and digital health.

Prior to joining Norwest, Irem worked at Summit Partners where she focused on healthcare growth stage businesses and was a board member or observer for four companies across risk-based providers and healthcare tech-enabled services. She was also a Principal at McKesson Ventures where she led investments in value-based care and pharma IT/services. Irem helped source or served as a board observer for Landmark Health (acquired by Optum), Aledade, IVX Health (recapped by Great Hill Partners), OncoHealth (formerly Oncology Analytics), SHYFT Analytics (acquired by Medidata), Aetion, Curana Health (formerly AllyAlign), Komodo Health, Kyruus and Evariant (acquired by Healthgrades).

Prior to joining McKesson, Irem was part of the founding team of Burd Health where she led the development and implementation of value-based initiatives for self-insured organizations across network management, pharmacy benefit management, and wellness products. She also served in product and business development roles with healthcare startups Omada Health and Caremerge (acquired by VoiceFriend) and was an intern at Andreessen Horowitz where she sourced digital health investments.

Irem started her career as an investment associate at Madison Dearborn Partners and an investment banking analyst in the Healthcare Group at Bank of America Merrill Lynch where she analyzed mergers and acquisitions for companies across life sciences, medical devices and healthcare services.

Irem holds a BS in biomedical engineering and economics, magna cum laude, from Duke University and an MBA from the Stanford Graduate School of Business, where she was an Arbuckle Leadership Fellow and Co-President of the Healthcare Club.